SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010152
Filing Date
2024-03-15
Accepted
2024-03-15 17:20:21
Documents
16
Period of Report
2024-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47398
2 ex99-1.htm EX-99.1 143901
  Complete submission text file 0001493152-24-010152.txt   435381

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bfri-20240315.xsd EX-101.SCH 3976
4 XBRL DEFINITION FILE bfri-20240315_def.xml EX-101.DEF 27432
5 XBRL LABEL FILE bfri-20240315_lab.xml EX-101.LAB 37886
6 XBRL PRESENTATION FILE bfri-20240315_pre.xml EX-101.PRE 26049
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6721
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24756036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)